1 results match your criteria: "China. cuiyixin@301hospital.com.cn.[Affiliation]"
Role and molecular mechanisms of HuangQiSiJunZi decoction for treating triple-negative breast cancer as explored via network pharmacology and bioinformatics analyses.
BMC Cancer
September 2024
Department of Traditional Chinese Medicine, The Sixth Medical Center of PLA General Hospital, Beijing, 100048, China.
Article Synopsis
- The study explores how the traditional Chinese medicine HuangQiSiJunZi Decoction (HQSJZD) may treat triple-negative breast cancer (TNBC) by examining its chemical components and their action targets using advanced bioinformatics tools.
- Key findings identified 256 potential targets for HQSJZD and 16 significant hub genes affecting TNBC, including FOS, which also plays a role in patient survival predictions.
- The research highlights the involvement of immune cells in TNBC while validating these findings through various analyses, supporting the potential effectiveness of HQSJZD in cancer treatment.